Global Virtual PLC and Soft PLC in Pharmaceutical market size was valued at USD 149.2 million in 2018 and grew to USD 266.9 million in 2024. It is anticipated to reach USD 649.1 million by 2032, expanding at a CAGR of 11.90% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
Virtual PLC and Soft PLC in Pharmaceutical Market Size 2024
USD 266.9 Million
Virtual PLC and Soft PLC in Pharmaceutical Market, CAGR
11.90%
Virtual PLC and Soft PLC in Pharmaceutical Market Size 2032
USD 649.1 Million
The Global Virtual PLC and Soft PLC in Pharmaceutical market is shaped by leading players such as Siemens, CODESYS Group, Copa-Data, Beckhoff Automation, ABB Ltd., and Delta Electronics, Inc., who compete through innovation in cloud-based platforms, IoT integration, and compliance-driven automation solutions. These companies focus on enhancing flexibility, scalability, and regulatory adherence to meet rising pharmaceutical automation needs. North America led the market with a 33.6% share in 2018, driven by advanced pharmaceutical manufacturing and stringent FDA requirements, while Asia Pacific is projected to expand fastest with a CAGR of 12.9%, supported by cost-effective drug production in China and India. Europe follows closely with 22.3% share in 2018, reflecting strong EMA-driven compliance adoption.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
The Global Virtual PLC and Soft PLC in Pharmaceutical market was valued at USD 149.2 million in 2018, reached USD 266.9 million in 2024, and is projected to hit USD 649.1 million by 2032, growing at a CAGR of 11.9%.
Market growth is driven by increasing automation in pharmaceutical production, with Soft PLC dominating by over 60% share in 2024, due to flexibility, cost efficiency, and easy integration with IoT and analytics platforms.
Key trends include the rapid adoption of cloud deployment, holding nearly 65% share in 2024, as firms seek scalability, predictive analytics, and global compliance readiness, while process automation leads applications with over 40% share.
The competitive landscape features Siemens, ABB, Beckhoff, CODESYS, Copa-Data, and Delta Electronics, focusing on product innovation, cloud-based control systems, and AI-driven compliance solutions.
Regionally, North America led with 33.6% share in 2018, while Asia Pacific is expanding fastest at 12.9% CAGR, supported by large-scale manufacturing hubs in China and India.
Market Segmentation Analysis:
By Product
The product segment of the Virtual PLC and Soft PLC in pharmaceutical market is divided into Virtual PLC and Soft PLC. Soft PLC held the dominant share of nearly 60% in 2024, driven by its flexibility, compatibility with existing hardware, and reduced cost of ownership. Pharmaceutical firms are adopting Soft PLC solutions to streamline automation in packaging lines and quality control systems without heavy investment in dedicated controllers. Growing demand for efficient integration with IoT platforms and real-time data analytics further strengthens the leadership of Soft PLC across pharmaceutical manufacturing operations.
For instance, Siemens continues to be a major provider of automation technology, including Soft PLC solutions, for the pharmaceutical industry, where it supports applications like packaging automation and electronic batch record compliance.
By Deployment
In terms of deployment, the market is segmented into cloud and on-premise solutions. Cloud deployment accounted for around 65% of the market in 2024, leading the segment due to rising adoption of digital transformation strategies in pharmaceutical facilities. The cloud model enables remote monitoring, faster scalability, and centralized control, which are critical for global operations and regulatory compliance. Growing investments in Industry 4.0 and cybersecurity frameworks further accelerate cloud adoption, while on-premise systems remain relevant for facilities requiring localized control and data security.
For instance, Rockwell Automation launched its PharmaSuite MES with cloud-enabled Soft PLC integration in 2023, allowing remote monitoring of over 100 production lines across multiple continents.
By Application
The application segment includes packaging & material handling, process automation, quality & compliance, maintenance & asset management, and others. Process automation led the segment with over 40% share in 2024, as pharmaceutical companies increasingly depend on automated workflows to improve production efficiency and reduce manual errors. Automated control systems in drug formulation, sterile manufacturing, and batch processing enhance consistency while meeting stringent regulatory requirements. The demand for validated, real-time monitoring systems to ensure compliance with FDA and EMA guidelines continues to drive strong adoption of process automation within pharmaceutical plants.
Key Growth Drivers
Rising Automation in Pharmaceutical Manufacturing
Pharmaceutical companies are rapidly shifting toward advanced automation to improve efficiency, reduce costs, and maintain regulatory compliance. Virtual PLC and Soft PLC systems allow streamlined control across packaging, formulation, and quality monitoring without requiring heavy investments in dedicated hardware. Adoption is fueled by the need for precise and consistent production, particularly in sterile environments where manual errors can impact product safety. With the rise of Industry 4.0, these solutions integrate seamlessly with IoT and smart sensors, enabling real-time monitoring of production lines. As drug manufacturing becomes more complex with biologics and personalized medicine, automation using software-based PLC platforms ensures scalability, flexibility, and faster validation processes, driving sustained demand across global facilities.
For instance, GSK has collaborated with Siemens on the digitalization of vaccine development and manufacturing processes, utilizing a ‘digital twin’ concept to simulate production and optimize operations. Separately, at its Ware facility, GSK has pursued automation initiatives with other software providers, such as AspenTech, to transition from manual to electronic batch records, reducing manual data entry.
Integration of Cloud-Based Solutions
The increasing adoption of cloud technology is a major driver for Virtual and Soft PLCs in the pharmaceutical sector. Cloud-based deployment models offer centralized monitoring, real-time data access, and predictive analytics across multiple facilities, making them highly attractive for multinational companies. This capability is vital for pharmaceutical firms managing global operations under stringent regulatory frameworks such as FDA and EMA guidelines. Cloud integration allows quick scalability to meet production surges, while also reducing IT infrastructure costs. Additionally, the ability to apply advanced AI and machine learning algorithms in the cloud enhances predictive maintenance, process optimization, and compliance reporting. The growing reliance on cloud platforms for connected manufacturing ecosystems is positioning cloud-enabled Virtual PLC and Soft PLC solutions as key enablers of digital transformation in pharmaceutical production.
For instance, Novartis deployed Rockwell Automation’s PharmaSuite MES with cloud-based Soft PLC integration in 2023, enabling predictive analytics and centralized monitoring across 14 global manufacturing facilities.
Growing Regulatory Focus on Quality and Compliance
Regulatory compliance is a central driver in the pharmaceutical industry, directly influencing automation system adoption. Virtual PLC and Soft PLC platforms offer precise control, real-time tracking, and advanced validation features that align with global compliance standards like GMP, FDA 21 CFR Part 11, and EMA requirements. The demand for audit-ready data management and electronic batch records encourages manufacturers to deploy these solutions for transparent reporting. With regulators increasingly emphasizing data integrity, error-proofing, and automated quality assurance, the adoption of software-driven PLCs is gaining momentum. By minimizing human intervention and providing traceable records, these systems help companies avoid costly recalls and maintain trust with healthcare providers. The pharmaceutical industry’s heightened focus on risk mitigation and continuous compliance ensures a strong growth outlook for Virtual PLC and Soft PLC solutions.
Key Trends & Opportunities
Expansion of Process Automation and Digital Twins
A major trend shaping the market is the adoption of digital twins and advanced process automation in pharmaceutical facilities. Virtual PLCs enable companies to simulate, test, and optimize production workflows before implementation, significantly reducing downtime and validation costs. This trend is creating opportunities for pharmaceutical firms to accelerate new drug production cycles and improve operational flexibility. By integrating digital twin technologies with Soft PLC platforms, manufacturers can predict performance, identify bottlenecks, and ensure compliance with regulatory standards in real-time. Growing investments in smart factories and continuous manufacturing processes are expected to further expand opportunities for software-driven automation solutions in the pharmaceutical sector.
For instance, in October 2022, Sanofi partnered with Dassault Systèmes to use its digital twin technology to optimize production at its new “EVolutive” vaccine facilities in France and Singapore.
Increasing Adoption of AI and Predictive Maintenance
The integration of AI-driven analytics with Virtual and Soft PLC systems is emerging as a key opportunity. Predictive maintenance, enabled by AI algorithms, reduces unplanned downtime and extends equipment life cycles in pharmaceutical facilities. By analyzing large data sets in real time, AI-enhanced PLC solutions can forecast potential failures and recommend preventive measures, ensuring continuous operations. This capability is particularly valuable in sterile drug manufacturing, where downtime can cause compliance risks and revenue losses. As pharmaceutical firms adopt AI-powered PLC platforms, opportunities for vendors providing intelligent and adaptive automation systems are growing rapidly.
Key Challenges
Cybersecurity Risks in Cloud-Based Deployments
While cloud-enabled Virtual and Soft PLC solutions bring scalability and connectivity benefits, they also expose pharmaceutical facilities to cybersecurity threats. Sensitive production data, regulatory records, and intellectual property stored in cloud environments remain vulnerable to breaches and cyberattacks. Any compromise in system security could disrupt production, delay compliance reporting, and harm patient safety. With rising adoption of remote monitoring and connected automation systems, pharmaceutical companies must invest heavily in cybersecurity infrastructure and advanced encryption protocols. This increases deployment costs and may hinder adoption in cost-sensitive regions. Ensuring secure and compliant cloud environments remains a critical challenge for the widespread adoption of Virtual and Soft PLCs in pharmaceuticals.
High Transition and Integration Costs
Another major challenge is the high cost and complexity of transitioning from legacy hardware-based PLC systems to Virtual and Soft PLC platforms. Many pharmaceutical facilities still operate with traditional automation frameworks that require significant reconfiguration for software-based solutions. The integration process often involves retraining staff, restructuring IT infrastructure, and upgrading production lines, all of which add to capital expenditure. Small and mid-sized manufacturers face barriers in justifying these investments, despite the long-term benefits. Additionally, the lack of skilled professionals capable of managing advanced PLC systems slows adoption rates. These factors pose hurdles to the rapid scaling of Virtual and Soft PLC systems across the pharmaceutical industry.
Regional Analysis
North America
North America accounted for the largest regional share, holding 33.6% of the market in 2018 with a size of USD 51.74 million. By 2024, the region expanded to USD 89.50 million and is forecasted to reach USD 207.73 million by 2032, growing at a CAGR of 11.2%. The dominance stems from strong pharmaceutical manufacturing bases in the U.S. and Canada, alongside heavy investments in Industry 4.0 adoption. Stringent FDA regulations encourage the use of automated, validated systems, boosting the adoption of Virtual PLC and Soft PLC platforms across packaging and quality control applications.
Europe
Europe represented 22.3% of the global market in 2018, valued at USD 34.34 million. The region’s size reached USD 60.38 million in 2024 and is projected to climb to USD 143.46 million by 2032, registering a CAGR of 11.6%. The market is driven by strong emphasis on compliance with EMA guidelines and increasing automation across pharmaceutical hubs in Germany, Switzerland, and the U.K. Rising demand for digital monitoring, predictive maintenance, and cloud deployment further supports adoption, positioning Europe as a key contributor to global Virtual PLC and Soft PLC integration.
Asia Pacific
Asia Pacific accounted for 25.4% of the market in 2018, with a value of USD 39.11 million. By 2024, it expanded to USD 74.30 million and is expected to reach USD 194.74 million by 2032, at the highest regional CAGR of 12.9%. Growth is driven by large-scale pharmaceutical production in India, China, and Japan, alongside expanding R&D facilities and cost-efficient manufacturing hubs. Governments promoting smart manufacturing initiatives and rapid adoption of IoT-based automation also fuel demand. Asia Pacific’s leadership in pharmaceutical exports strengthens its role as the fastest-growing region for Virtual PLC and Soft PLC systems.
Latin America
Latin America represented 8.6% of the market in 2018, valued at USD 13.30 million. The region grew to USD 23.98 million in 2024 and is forecasted to reach USD 58.94 million by 2032, recording a CAGR of 12.0%. Brazil and Mexico lead adoption, supported by growing pharmaceutical outsourcing and modernization of production facilities. Regional companies are investing in advanced automation to align with international quality standards, creating opportunities for Virtual PLC and Soft PLC providers. Increasing regulatory reforms and expanding generic drug production also support higher demand across the region.
Middle East
The Middle East accounted for 4.6% of the global market in 2018, valued at USD 7.13 million. By 2024, it reached USD 12.51 million and is projected to expand to USD 29.60 million by 2032, advancing at a CAGR of 11.5%. Growth is supported by investments in pharmaceutical manufacturing under diversification initiatives, particularly in Saudi Arabia and the UAE. Adoption of advanced automation systems helps local manufacturers meet export standards and regulatory requirements. The demand for high-quality production and reduced operational risks makes Virtual PLC and Soft PLC solutions increasingly relevant in this region.
Africa
Africa held a smaller share of 2.3% in 2018, with a market size of USD 3.61 million. The region grew to USD 6.28 million in 2024 and is projected to reach USD 14.67 million by 2032, growing at a CAGR of 11.3%. Pharmaceutical production across South Africa, Nigeria, and Egypt is modernizing, driving early adoption of digital automation. Local challenges in compliance and production efficiency are encouraging facilities to invest in scalable and cost-effective Virtual PLC and Soft PLC systems. While adoption is gradual, Africa presents long-term opportunities as governments increase focus on local drug manufacturing.
Market Segmentations:
By Product
Virtual PLC
Soft PLC
By Deployment
Cloud
On-premise
By Application
Packaging & Material Handling
Process Automation
Quality & Compliance
Maintenance & Asset Management
Others
By Geography
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
Competitive Landscape
The competitive landscape of the Global Virtual PLC and Soft PLC in Pharmaceutical market is characterized by the presence of established automation leaders and specialized solution providers. Key players such as Siemens, CODESYS Group, Copa-Data, Beckhoff Automation, ABB Ltd., and Delta Electronics dominate the market with extensive product portfolios and strong global reach. These companies focus on integrating cloud-based platforms, IoT connectivity, and AI-driven analytics to support pharmaceutical manufacturers in achieving regulatory compliance, operational efficiency, and process optimization. Strategic moves such as partnerships, product launches, and expansions into emerging markets remain central to their growth. For instance, Siemens and ABB emphasize smart automation platforms tailored to pharmaceutical production, while CODESYS and Copa-Data provide flexible software solutions for virtual control. With rising demand for validated, secure, and scalable automation systems, competition is intensifying, driving continuous innovation and investment across the industry.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In January 2025, Beckhoff Automation announced a partnership with Riedel, a manufacturer of communication systems, to simplify the integration of their respective control technologies for entertainment venues.
In July 2025, Delta Electronics announced a partnership with Microchip Technology to incorporate Microchip’s mSiC™ (silicon carbide) technology into its power management and smart energy solutions, targeting high-growth sectors like artificial intelligence and e-mobility.
In February 2025, Mitsubishi Electric revealed a new technology that enhances system maintenance by visualizing and sharing know-how derived from operator experience.
In July 2023, Schneider Electric announced a partnership with leading software vendors to enhance the integration of soft PLCs into their EcoStruxure platform. This collaboration aims to provide customers with more flexible and scalable automation solutions.
In September 2023, ABB introduced new virtualized control solutions that leverage soft PLC technology to enhance industrial automation processes. These solutions aim to improve system responsiveness and reduce operational costs.
Report Coverage
The research report offers an in-depth analysis based on Product, Deployment, Application and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
The market will witness steady adoption of cloud-based Virtual PLC and Soft PLC platforms.
Pharmaceutical firms will prioritize automation to improve compliance and reduce operational risks.
Soft PLC solutions will continue to dominate due to flexibility and integration advantages.
Virtual PLC adoption will grow as digital twins and simulation tools gain traction.
AI-enabled predictive maintenance will become a standard feature in pharmaceutical facilities.
Asia Pacific will emerge as the fastest-growing region with strong manufacturing expansion.
North America will maintain leadership supported by strict FDA-driven compliance needs.
Vendors will invest in cybersecurity to secure cloud-based automation systems.
Partnerships between automation providers and pharmaceutical firms will intensify global reach.
Long-term opportunities will rise from continuous manufacturing and personalized medicine production.
CHAPTER NO. 1 : GENESIS OF THE MARKET
1.1 Market Prelude – Introduction & Scope
1.2 The Big Picture – Objectives & Vision
1.3 Strategic Edge – Unique Value Proposition
1.4 Stakeholder Compass – Key Beneficiaries CHAPTER NO. 2 : EXECUTIVE LENS
2.1 Pulse of the Industry – Market Snapshot
2.2 Growth Arc – Revenue Projections (USD Million)
2.3. Premium Insights – Based on Primary Interviews CHAPTER NO. 3 : VIRTUAL PLC AND SOFT PLC IN PHARMACEUTICAL MARKET FORCES & INDUSTRY PULSE
3.1 Foundations of Change – Market Overview
3.2 Catalysts of Expansion – Key Market Drivers
3.2.1 Momentum Boosters – Growth Triggers
3.2.2 Innovation Fuel – Disruptive Technologies
3.3 Headwinds & Crosswinds – Market Restraints
3.3.1 Regulatory Tides – Compliance Challenges
3.3.2 Economic Frictions – Inflationary Pressures
3.4 Untapped Horizons – Growth Potential & Opportunities
3.5 Strategic Navigation – Industry Frameworks
3.5.1 Market Equilibrium – Porter’s Five Forces
3.5.2 Ecosystem Dynamics – Value Chain Analysis
3.5.3 Macro Forces – PESTEL Breakdown CHAPTER NO. 4 : KEY INVESTMENT EPICENTER
4.1 Regional Goldmines – High-Growth Geographies
4.2 Product Frontiers – Lucrative Product Categories
4.3 Application Sweet Spots – Emerging Demand Segments CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING
5.1 Momentum Metrics – Forecast & Growth Curves
5.2 Regional Revenue Footprint – Market Share Insights
5.3 Segmental Wealth Flow – Product, Deployment, and Application Revenue CHAPTER NO. 6 : TRADE & COMMERCE ANALYSIS
6.1. Import Analysis By Region
6.1.1. Global Virtual PLC and Soft PLC in Pharmaceutical Market Import Revenue By Region
6.2. Export Analysis By Region
6.2.1. Global Virtual PLC and Soft PLC in Pharmaceutical Market Export Revenue By Region CHAPTER NO. 7 : COMPETITION ANALYSIS
7.1. Company Market Share Analysis
7.1.1. Global Virtual PLC and Soft PLC in Pharmaceutical Market: Company Market Share
7.2. Global Virtual PLC and Soft PLC in Pharmaceutical Market Company Revenue Market Share
7.3. Strategic Developments
7.3.1. Acquisitions & Mergers
7.3.2. New Product Launch
7.3.3. Regional Expansion
7.4. Competitive Dashboard
7.5. Company Assessment Metrics, 2024 CHAPTER NO. 8 : VIRTUAL PLC AND SOFT PLC IN PHARMACEUTICAL MARKET – BY PRODUCT SEGMENT ANALYSIS
8.1. Virtual PLC and Soft PLC in Pharmaceutical Market Overview By Product Segment
8.1.1. Virtual PLC and Soft PLC in Pharmaceutical Market Revenue Share By Product
8.2. Virtual PLC
8.3. Soft PLC CHAPTER NO. 9 : VIRTUAL PLC AND SOFT PLC IN PHARMACEUTICAL MARKET – BY DEPLOYMENT SEGMENT ANALYSIS
9.1. Virtual PLC and Soft PLC in Pharmaceutical Market Overview By Deployment Segment
9.1.1. Virtual PLC and Soft PLC in Pharmaceutical Market Revenue Share By Deployment
9.2. Cloud
9.3. On-premise CHAPTER NO. 10 : VIRTUAL PLC AND SOFT PLC IN PHARMACEUTICAL MARKET – BY APPLICATION SEGMENT ANALYSIS
10.1. Virtual PLC and Soft PLC in Pharmaceutical Market Overview By Application Segment
10.1.1. Virtual PLC and Soft PLC in Pharmaceutical Market Revenue Share By Application
10.2. Packaging & Material Handling
10.3. Process Automation
10.4. Quality & Compliance
10.5. Maintenance & Asset Management
10.6. Others CHAPTER NO. 11 : VIRTUAL PLC AND SOFT PLC IN PHARMACEUTICAL MARKET – REGIONAL ANALYSIS
11.1. Virtual PLC and Soft PLC in Pharmaceutical Market Overview By Region Segment
11.1.1. Global Virtual PLC and Soft PLC in Pharmaceutical Market Revenue Share By Region
10.1.2. Regions
11.1.3. Global Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Region
11.1.4. Product
11.1.5. Global Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Product
11.1.6. Deployment
11.1.7. Global Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Deployment
11.1.8. Application
11.1.9. Global Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Application CHAPTER NO. 12 : NORTH AMERICA VIRTUAL PLC AND SOFT PLC IN PHARMACEUTICAL MARKET – COUNTRY ANALYSIS
12.1. North America Virtual PLC and Soft PLC in Pharmaceutical Market Overview By Country Segment
12.1.1. North America Virtual PLC and Soft PLC in Pharmaceutical Market Revenue Share By Region
12.2. North America
12.2.1. North America Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Country
12.2.2. Product
12.2.3. North America Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Product
12.2.4. Deployment
12.2.5. North America Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Deployment
12.2.6. Application
12.2.7. North America Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Application
12.3. U.S.
12.4. Canada
12.5. Mexico CHAPTER NO. 13 : EUROPE VIRTUAL PLC AND SOFT PLC IN PHARMACEUTICAL MARKET – COUNTRY ANALYSIS
13.1. Europe Virtual PLC and Soft PLC in Pharmaceutical Market Overview By Country Segment
13.1.1. Europe Virtual PLC and Soft PLC in Pharmaceutical Market Revenue Share By Region
13.2. Europe
13.2.1. Europe Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Country
13.2.2. Product
13.2.3. Europe Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Product
13.2.4. Deployment
13.2.5. Europe Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Deployment
13.2.6. Application
13.2.7. Europe Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Application
13.3. UK
13.4. France
13.5. Germany
13.6. Italy
13.7. Spain
13.8. Russia
13.9. Rest of Europe CHAPTER NO. 14 : ASIA PACIFIC VIRTUAL PLC AND SOFT PLC IN PHARMACEUTICAL MARKET – COUNTRY ANALYSIS
14.1. Asia Pacific Virtual PLC and Soft PLC in Pharmaceutical Market Overview By Country Segment
14.1.1. Asia Pacific Virtual PLC and Soft PLC in Pharmaceutical Market Revenue Share By Region
14.2. Asia Pacific
14.2.1. Asia Pacific Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Country
14.2.2. Product
14.2.3. Asia Pacific Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Product
14.2.4. Deployment
14.2.5. Asia Pacific Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Deployment
14.2.6. Application
14.2.7. Asia Pacific Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Application
14.3. China
14.4. Japan
14.5. South Korea
14.6. India
14.7. Australia
14.8. Southeast Asia
14.9. Rest of Asia Pacific CHAPTER NO. 15 : LATIN AMERICA VIRTUAL PLC AND SOFT PLC IN PHARMACEUTICAL MARKET – COUNTRY ANALYSIS
15.1. Latin America Virtual PLC and Soft PLC in Pharmaceutical Market Overview By Country Segment
15.1.1. Latin America Virtual PLC and Soft PLC in Pharmaceutical Market Revenue Share By Region
15.2. Latin America
15.2.1. Latin America Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Country
15.2.2. Product
15.2.3. Latin America Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Product
15.2.4. Deployment
15.2.5. Latin America Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Deployment
15.2.6. Application
15.2.7. Latin America Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Application
15.3. Brazil
15.4. Argentina
15.5. Rest of Latin America CHAPTER NO. 16 : MIDDLE EAST VIRTUAL PLC AND SOFT PLC IN PHARMACEUTICAL MARKET – COUNTRY ANALYSIS
16.1. Middle East Virtual PLC and Soft PLC in Pharmaceutical Market Overview By Country Segment
16.1.1. Middle East Virtual PLC and Soft PLC in Pharmaceutical Market Revenue Share By Region
16.2. Middle East
16.2.1. Middle East Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Country
16.2.2. Product
16.2.3. Middle East Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Product
16.2.4. Deployment
16.2.5. Middle East Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Deployment
16.2.6. Application
16.2.7. Middle East Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Application
16.3. GCC Countries
16.4. Israel
16.5. Turkey
16.6. Rest of Middle East CHAPTER NO. 17 : AFRICA VIRTUAL PLC AND SOFT PLC IN PHARMACEUTICAL MARKET – COUNTRY ANALYSIS
17.1. Africa Virtual PLC and Soft PLC in Pharmaceutical Market Overview By Country Segment
17.1.1. Africa Virtual PLC and Soft PLC in Pharmaceutical Market Revenue Share By Region
17.2. Africa
17.2.1. Africa Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Country
17.2.2. Product
17.2.3. Africa Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Product
17.2.4. Deployment
17.2.5. Africa Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Deployment
17.2.6. Application
17.2.7. Africa Virtual PLC and Soft PLC in Pharmaceutical Market Revenue By Application
17.3. South Africa
17.4. Egypt
17.5. Rest of Africa CHAPTER NO. 18 : COMPANY PROFILES
18.1. Siemens
18.1.1. Company Overview
18.1.2. Product Portfolio
18.1.3. Financial Overview
18.1.4. Recent Developments
18.1.5. Growth Strategy
18.1.6. SWOT Analysis
18.2. CODESYS Group
18.3. Copa-Data
18.4. Beckhoff Automation
18.5. ABB Ltd.
18.6. Delta Electronics, Inc.
18.7. Other Key Players
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the current market size for Global Virtual PLC and Soft PLC in Pharmaceutical market, and what is its projected size in 2032?
The market size was USD 266.9 million in 2024 and is projected to reach USD 649.1 million by 2032.
At what Compound Annual Growth Rate is the Global Virtual PLC and Soft PLC in Pharmaceutical market projected to grow between 2025 and 2032?
The market is projected to grow at a CAGR of 11.90% during 2025–2032.
Which Global Virtual PLC and Soft PLC in Pharmaceutical market segment held the largest share in 2024?
Soft PLC held the largest share, accounting for over 60% in 2024.
What are the primary factors fueling the growth of the Global Virtual PLC and Soft PLC in Pharmaceutical market?
Growth is fueled by rising automation, cloud adoption, and increasing regulatory compliance requirements.
Who are the leading companies in the Global Virtual PLC and Soft PLC in Pharmaceutical market?
Key players include Siemens, CODESYS Group, Copa-Data, Beckhoff Automation, ABB Ltd., and Delta Electronics.
Which region commanded the largest share of the Global Virtual PLC and Soft PLC in Pharmaceutical market in 2024?
North America commanded the largest share, driven by advanced pharmaceutical manufacturing and FDA compliance.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The Europe Pharmaceutical Contract Sales Organizations Market is projected to grow from USD 2,635.17 million in 2024 to an estimated USD 4,772.90 million by 2032, with a compound annual growth rate (CAGR) of 7.71% from 2024 to 2032.
The Joint Pain Injections market size was valued at USD 2,680.0 million in 2018 to USD 3,485.1 million in 2024 and is anticipated to reach USD 6,253.3 million by 2032, at a CAGR of 7.63% during the forecast period.
The Global Thebaine Market size was valued at USD 89.4 million in 2018 to USD 131.4 million in 2024 and is anticipated to reach USD 222.1 million by 2032, at a CAGR of 6.81% during the forecast period.
The Specialty Pharmaceuticals Market size was valued at USD 225.73 billion in 2024 and is anticipated to reach USD 1461.55 billion by 2032, at a CAGR of 26.3% during the forecast period (2024-2032).
The PET packaging in pharmaceutical market was valued at USD 7,498.00 million in 2024 and is projected to reach USD 11,162.65 million by 2032, growing at a CAGR of 5.1% during the forecast period.
Whole Genome Sequencing Market size was valued USD 2.23 billion in 2024 and is anticipated to reach USD 10.86 billion by 2032, at a CAGR of 21.9% during the forecast period.
Thyroid Gland Disorder Treatment Market size was valued USD 2.49 billion in 2024 and is anticipated to reach USD 3.14 billion by 2032, at a CAGR of 2.98% during the forecast period.
The pharmaceutical software market size was valued at USD 33.79 billion in 2024 and is anticipated to reach USD 64.41 billion by 2032, at a CAGR of 8.4 % during the forecast period (2024-2032).
The OTC vitamins dietary supplements market is projected to witness substantial growth, with its value expected to surge from USD 89,997.70 million in 2023 to USD 180,997.70 million by 2032, reflecting a robust CAGR of 5.9%.
The Pharmaceutical Desiccants Market size was valued at USD 107.17 million in 2024 and is anticipated to reach USD 151.01 million by 2032, at a CAGR of 4.38% during the forecast period (2024-2032).
Pharmacy Repackaging System Market size was valued USD 1701.53 million in 2024 and is anticipated to reach USD 2763.57 million by 2032, at a CAGR of 6.25% during the forecast period.
Pharmaceutical Secondary Packaging Market size was valued USD 43,273.30 Million in 2024 and is anticipated to reach USD 61,727.68 Million by 2032, at a CAGR of 4.54% during the forecast period.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$6999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
